Qualitative Analysis of Pain in Patients With Locally Advanced or Metastatic Urothelial Carcinoma
Bladder Cancer · 08.10.2021 · 8 (1) · 45-53
DOI: 10.3233/blc-211518 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bladder Cancer, online erschienen am 28.11.2021. Verfasst von Susan Martin und 4 weiteren Autor:innen. Beteiligte Einrichtung: RTI International, Raleigh, NC, USA. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
BACKGROUND: Pain is not well described in patients with locally advanced or metastatic urothelial cancer (la/mUC). OBJECTIVE: To characterize pain and assess the content validity of the Brief Pain Inventory Short Form (BPI-SF) worst pain item in patients with la/mUC receiving first-line treatment in the US. METHODS: Qualitative interviews were conducted in patients aged≥45 years with confirmed la/mUC, self-reported la/mUC-attributed pain before enrollment, and no major surgery≤3 months prior to being interviewed. Interview participants were asked open-ended questions about their la/mUC symptoms and pain. “Think aloud” cognitive debriefing was conducted for the BPI-SF worst pain item. RESULTS: Ten participants with laUC and six (38%) with mUC were interviewed. First-line treatments included cisplatin ( n = 14; 88%) or carboplatin ( n = 2; 13%). The average past-week worst pain score (0–10 scale) was 6.2 (range, 3–10); seven (44%) participants reported severe pain (score≥7). Pain was most frequently reported in the back ( n = 14; 88%) and/or pelvic/lower abdominal area ( n = 10; 63%). Pain impacted all participants’ physical and daily activities; 81% reported it impacted their overall quality of life. All participants interpreted and completed the BPI-SF worst pain item without difficulty; 15 (94%) reported it was relevant to their la/mUC experience. Participants understood the 24-hour recall period; most supported daily ( n = 13; 81%) or weekly ( n = 14; 88%) assessment, preferring electronic administration using their phone ( n = 14; 88%). CONCLUSIONS: Pain attributed to la/mUC impacted physical and daily activities in all participants undergoing first-line treatment for la/mUC. Content validity was demonstrated for the BPI-SF worst pain item in this population.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- RTI International, Raleigh, NC, USA.
- Astellas Pharma, Inc., Northbrook, IL, USA.
- Seagen Inc., Bothell, WA, USA.
- Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Zitieren
APA
Martin, S., Shah, S. N., Hepp, Z., Harris, N., & Morgans, A. K. (2021). Qualitative Analysis of Pain in Patients With Locally Advanced or Metastatic Urothelial Carcinoma. Bladder Cancer, 8(1), 45-53. https://doi.org/10.3233/blc-211518
Vancouver
Martin S, Shah SN, Hepp Z, Harris N, Morgans AK. Qualitative Analysis of Pain in Patients With Locally Advanced or Metastatic Urothelial Carcinoma. Bladder Cancer. 2021;8(1):45-53. doi:10.3233/blc-211518
BibTeX
@article{Martin2021,
author = {Martin, Susan and Shah, Sonali N and Hepp, Zsolt and Harris, Nimanee and Morgans, Alicia K},
title = {Qualitative Analysis of Pain in Patients With Locally Advanced or Metastatic Urothelial Carcinoma},
journal = {Bladder Cancer},
year = {2021},
volume = {8},
number = {1},
pages = {45--53},
doi = {10.3233/blc-211518}
}
EUVIMED